S&P 500 · Health Care · USD · FY end 2025-12-31
Gilead Sciences (GILD) financials — revenue, earnings, margins, balance sheet, cash flow and dividends. 10-year history sourced from SEC filings.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| FY2025 | 29.44B | 8.51B | 6.78 | 9.46B |
| FY2024 | 28.75B | 480.00M | 0.38 | 10.30B |
| FY2023 | 27.12B | 5.67B | 4.50 | 7.42B |
| FY2022 | 27.28B | 4.59B | 3.64 | 8.34B |
| FY2021 | 27.30B | 6.22B | 4.93 | 10.80B |